ArticleFrontiers in medicine2026
The application value of preoperative magnetic resonance cholangiopancreatography in predicting the success of endoscopic retrograde cholangiopancreatography stone removal.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Common bile duct stones (CBDS) are a common disease. Endoscopic retrograde cholangiopancreatography (ERCP) is currently recognized as the preferred treatment method for CBDS. However, there are cases that cannot be removed through ERCP. Therefore, the aim of this study is to explore the value of magnetic resonance cholangiopancreatography (MRCP) in assessing the success of CBDS removal through ERCP. Patients and methods: A total of 432 CBDS patients were include in this study. According to whether the stone removal was successful in ERCP, the patients were divided into the successful stone removal group and the failed stone removal group. The differences in MRCP-related parameters between the two groups were analyzed. Results: This multi-center study included a total of 175 male CBDS patients and 257 female CBDS patients. A total of 395 CBDS patients successfully removed stones through ERCP, with a success rate of 91.44%. There were significant differences in the stone diameter ( Conclusion: The results of this study confirm that preoperative MRCP plays a significant role in assessing the success of ERCP stone removal in CBDS patients. The stone diameter >15 mm was identified as an independent risk factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.